Learning Objectives:

1. Identify the role of TRBV9 in the pathogenesis of ankylosing spondylitis 

2. Evaluate the efficacy of a novel therapeutic on both clinical and immunological outcomes

 

Session date: 
10/08/2024 - 8:30am to 9:30am CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Maja Ivanovic, MD